Picture of two a poster presentation at an event and the words News and Events
James Moon
Twenty-Nine U-M College of Pharmacy Faculty Among the World’s Top 2% of Scientists
December 3, 2025

Congratulations to Dr. James Moon, Dr. Steven Schwendeman, Dr. Anna Schwendeman, Dr. Guizhi (Julian) Zhu, and Dr. Peter Tessier on being named as apart of 2025’s World’s Top 2% Scientists Network!

Their continued impact on the scientific community is inspiring!

Read Story
Dr. James Moon, Dr. Steven Schwendeman, Dr. Anna Schwendeman, Dr. Guizhi (Julian) Zhu, and Dr. Peter Tessier
Celebrating U-M College of Pharmacy Leaders in Global Research: Moon, Schwendemans, Zhu & Tessier Recognized in Top 2%
December 3, 2025

Congratulations to Dr. James Moon, Dr. Steven Schwendeman, Dr. Anna Schwendeman, Dr. Guizhi (Julian) Zhu, and Dr. Peter Tessier on being named as apart of 2025’s World’s Top 2% Scientists Network!

Their continued impact on the scientific community is inspiring!

Read Story
Deepak Nagrath
Digital-Twin Models Bring Patient-Level Metabolic Flux Analysis to Brain Cancer
December 1, 2025

A new study by the Deepak Nagrath lab unveils two machine-learning, powered frameworks that estimate metabolic fluxes directly in brain-cancer patients, a major advance over prior studies limited to preclinical models.

Read Story
Peter Tessier
Hijacking the Brain’s Highways for Better Therapies
November 20, 2025

“We want to inject large molecules — proteins, peptides, nucleic acids — into the bloodstream and have them cross the blood-brain barrier in an efficient and predictable way to get them into the brain interior,” – Dr. Peter Tessier

Read Story
Colin Greineder
A New Era for Bone Health Begins, Dr. Greineder’s Latest Venture
November 17, 2025

Skeletalis is now live, driven by Colin Greineder and his fellow cofounders’ pioneering work in bone-targeted therapeutics.

Osteoporosis affects over 10 million adults in the U.S., yet current treatments still fall short. Their team is rethinking how osteoporosis drugs interact with bone, aiming for safer, more durable therapies that truly meet patient needs.

This is the future of skeletal health, and they’re building it now.

 

Read Story
Lonnie Shea
U-M Awards New Commercialization Fellowships: Including Shea Lab Innovator
November 14, 2025

Among the awardees is Brian Ross (PI: Lonnie Shea lab), whose work on advanced cell-capture scaffolding is advancing toward real-world impact under the startup Porosity Bio.

Read Story
Dr. Maria Castro and Dr. Pedro Lowenstein performing research on high-grade gliomas
Expanding Mind & Matter: Turning Brain Tumors into Manageable Conditions
November 11, 2025

“When the tumor progresses 10 years later, there are no treatments. That’s what this grant is about: to develop treatment for when this disease comes back and becomes deadly… In this grant we will investigate how these immune cells are modified, how the tumor cells talk to the bone marrow, and how these reprogrammed immune cells go back into the brain microenvironment to modify the immune response against the tumor,” – Dr. Maria Castro

Read Story
Joerg Lahann
Turning Health Research Inside Out: Collaboration as the Catalyst for Discovery
November 3, 2025

“The Institute comes at research from the opposite direction—we start by asking “what’s the big problem we want to solve?” And by starting with the big picture, we can identify all the different domains that need to be involved and enable them to work together as a team from the outset,” – Dr. Joerg Lahann

Read Story
Sunitha Nagrath
Advancement in Noninvasive Blood Test to Guide Breast Cancer Treatment Decisions
October 29, 2025

A groundbreaking study led by Dr. Sunitha Nagrath and Dr. Max Wicha is bringing precision medicine one step closer to reality. Their team has developed an innovative “labyrinth” microfluidic chip that can capture circulating tumor cells (CTCs) from a simple blood sample. By isolating and analyzing cancer cells directly from the bloodstream, the research opens the door to noninvasive, real-time insights into tumor biology and treatment response. It’s a major leap toward personalized cancer care.

Read Story
James Moon
AI Meets Single-Cell Biology: Next-Gen Biomedical Models
October 23, 2025

Researchers are exploring how large language models (LLMs) can revolutionize single-cell biology. Their new paper highlights how “single-cell LLMs” could accelerate discovery in genomics, disease modeling, and personalized medicine. The team also calls for open collaboration, standardized datasets, and transparency to make AI-driven biology more reliable and accessible.

Read Story
BI Research Week Recap
October 23, 2025

The Biointerfaces Institute hosted our first ever Research Week! An expansion of our previously established Research Day, BI hosted a plethora of events expressive of our institutions dedication to innovative science!

We give our appreciation to those who participated in our events, and we are glad so many were able to join us!

Read Story
Sharon Glotzer
From Pottery to Nanotech: Engineers Stencil Nanoparticles to Build Next-gen Materials
October 20, 2025

“One of the holy grails of nanoscience has been to make designer building blocks out of any material and then dictate exactly how they stick to each other” – Dr. Sharon Glotzer

Read Story
Tim Bruns
How Nerves Talk Back: Uncover Hidden Dynamics in Electrical Stimulation
October 7, 2025

New research from Dr. Tim Bruns’ lab reveals how peripheral nerves are far from passive targets during electrical stimulation. They actively shape how they respond, based on their ongoing physiological activity.

Read Story
Joerg Lahann
Targeted Prevention: Nanoparticles Aimed at Stopping Oral Cancer Before It Starts
September 30, 2025

Dr. Joerg Lahann and graduate research assistant Albert Chang are developing nanoparticles that stick to the mouth’s mucosal layer, delivering chemopreventive drugs directly to high-risk areas. This controlled, targeted approach aims to reduce oral cancer risk while sparing healthy tissue.

Read Story
Carlos Aguilar
Beyond the Scar: ECM Hydrogels Unlock New Paths for Muscle Recovery
September 29, 2025

Dr. Carlos Aguilar and his team demonstrate how ECM hydrogels can transform the healing of severe muscle injuries. Using advanced spatial transcriptomics, they show the treatment limits harmful immune and scar-forming cells while promoting muscle progenitors—shifting repair away from fibrosis and toward true regeneration.

Read Story

The Biointerfaces Institute brings extensive experience to the collaborations that lead to scientific breakthroughs, successful translation, and advanced learning.

Contact Us